Infusing the patient voice into every stage of drug development

We work with our biopharmaceutical, nonprofit, and regulatory partners to better understand disease impacts, unmet needs, and patient preferences.

Our approach

Canary Advisors® partners with biopharma, nonprofit, and regulatory stakeholders to better align clinical development programs with patient wants and needs.

There's no one size fits all solution to advocacy. Our services are tailor-made to match the needs of the patient communities our partners serve.

Canary Advisors team.
Canary Advisors team.

Our services

No matter the project, Canary Advisors works to better align clinical development with patient wants and needs. We do this by building longterm, mutually beneficials relationships between our clients and communities served, gathering impactful insights, and infusing them into our client's work. Areas of specialization include patient experience data collection, access and reimbursement support, and concierge trial travel and reimbursement.

Patient Experience Data Collection

Regulatory and Legislative Patient Advocacy

Early Stage Patient Advocacy

Non-profit Development

Access, Launch, and Reimbursement

Canary Concierge

  • “The Akouos team would like to recognize and thank Canary Advisors® for the support extended to one of our clinical participants and their family. From organizing travel logistics, to securing an interpreter, to creating a welcome guide to the city, Canary Advisors® was instrumental in assisting the family."

  • “…Canary Advisors® is exceptional at meeting corporate strategic imperatives by incorporating the patient/caregiver perspective. Whether it’s advocacy landscape mapping, regulatory planning, or reimbursement support, Canary was able to provide options and solutions to meet our organization’s needs.”

    Tricia S., Biotech Client

  • “Jenn and Richie’s knowledge and experience in non-profits, industry, and rare disease are invaluable. They have guided our organization through several large-scale projects, including an externally led Patient Focused Drug Development meeting. We continue to use their expertise to help drive our organization forward.”

    Amy S., Executive Director, Lung Transplant Foundation

  • "If you are looking for a patient-focused drug and device development consultancy agency, I highly recommend Canary Advisors®. They are experts in connecting with patients and developing strategies that prioritize patient needs and preferences. They have an unrivaled ability to apply patient-centered design principles to ensure that drugs and devices are not only safe and effective but also meet the needs and preferences of the people who will be using them."

    Carolina S, Co-Founder, Marketing & Strategy Director, Science2People

  • "It’s always an honor to serve the rare community. Working alongside such an AMAZING team with Canary Advisors® makes it even better! Many thanks to Jennifer McNary and Richie Kahn for their hard work and dedication! It’s a privilege to call you colleagues, and even more importantly, friends!"

    Karen U., Non-Profit Leader

  • “Over the years, we’ve partnered with a good number of organizations representing patients and the patient voice, but none have been more responsive, impactful and innovative than Canary Advisors. Plus, both Jenn McNary and Richie Kahn are an absolute delight to work with.”

    Andrew R., Co-Founder, Government Relations firm

  • "Our work with Canary advisors has been very productive and they have been very response and easy to work with. The team has great experience and quickly helped us formulate a plan to understand the landscape and engage with the patient community. The initial focus groups yielded very insightful input and clear next steps for building relationships and incorporating patient input into our development plans."

    Bernard R., Biotech Client

  • "Working with Canary Advisors was a great experience as they brought valuable expertise in incorporating the patient perspective into drug development. Their collaborative approach and deep understanding of aligning clinical programs with unmet needs of the patient community made them excellent thought partners. They were easy to work with and ensured the project aligned with our company’s strategic priorities."

    Seth R., Biotech Client

  • “I’m finally coming up for air after Wednesday :-) thank you thank you thank you for everything these past weeks! You are an absolute godsend! We really couldn’t have done [our patient listening session] it without you. So more thanks than I can possibly express!"

    Sarah G., Patient Advocacy Leader

Ready to get started?